论文部分内容阅读
近年来,我国政府对药品价格虚高采取了一系列措施,但是效果不显著。本文对我国现阶段的药品价格管理模式的现状和弊端加以详细分析,指出药价的真实成本核实难、药价畸形竞争治理难等药品价格管理问题,最后提出了政府应该从药品定价制度和药品监管体制上来进一步规范药品价格的建议。
In recent years, the Chinese government has taken a series of measures against the high price of drugs, but the effect is not significant. This article analyzes in detail the current status and disadvantages of the drug price management model in China at this stage, and points out that drug price management problems such as the real cost verification of drug prices, drug price distortion and competition management difficulties, and finally put forward that the government should start from the drug pricing system and drugs. Regulatory system to further regulate the drug price recommendations.